Company Update1 Min Read InvestyWise NewsonSeptember 3, 2026 NLC India: CRISIL Reaffirms AAA/Stable Rating for ₹11,640 Crore Debt NLC India Limited has had its credit ratings reaffirmed by CRISIL Ratings Limited. The company’s total bank loan facilities amounting to…
Other Announcements1 Min Read InvestyWise NewsonSeptember 3, 2026 CG-VAK: Directors Recommend 10% Dividend of ₹1 Per Share CG-VAK Software and Exports Limited has announced that its Directors have recommended a dividend of ₹1 per equity share, representing a 10%…
Company Update2 Min Read InvestyWise NewsonSeptember 3, 2026 Orchid Pharma: Appoints Arjun Dhanuka as Whole-Time Director Orchid Pharma Limited announced the appointment of Mr. Arjun Dhanuka as a Whole-Time Director during its Board Meeting on September 03, 2026.…
Company Update2 Min Read InvestyWise NewsonSeptember 3, 2026 Ceigall India: Discloses AGM Details and Annual Report Access Ceigall India Limited has issued a notice regarding its 24th Annual General Meeting (AGM), scheduled for Tuesday, September 29, 2026, at 02:30…
Other Announcements2 Min Read InvestyWise NewsonSeptember 3, 2026 Puravankara: Reports Record FY26 Sales of ₹7,407 Crore, Turns Profitable Puravankara Limited has announced a landmark financial year 2025-26, marked by record-breaking sales of ₹7,407 crore, a significant increase…
Other Announcements2 Min Read InvestyWise NewsonSeptember 3, 2026 Ceigall India: Reports Strong Financials for FY 2025-26, Outlines Growth Strategy Ceigall India Limited has released its Annual Report for the Financial Year 2025-2026, highlighting robust financial performance and outlining…
Corporate Action2 Min Read InvestyWise NewsonSeptember 3, 2026 Nilachal Refractories: Sets Record Date for 49th AGM Nilachal Refractories Limited has announced the record date for its 49th Annual General Meeting (AGM). The 19th of September, 2026, has been…
Other Announcements2 Min Read InvestyWise NewsonSeptember 3, 2026 Orchid Pharma: Board Appoints Arjun Dhanuka as Whole-Time Director Orchid Pharma Limited’s Board of Directors convened on September 03, 2026, approving key appointments and forward-looking financial…
Other Announcements2 Min Read InvestyWise NewsonSeptember 3, 2026 Pharmaasia Ltd.: Posts ₹1757 Cr Net Profit in FY26, Up From Loss Pharmaasia Limited announced a substantial turnaround in its financial performance for the fiscal year ended March 31, 2026. The company…
Company Update2 Min Read InvestyWise NewsonSeptember 3, 2026 Cohance Lifesciences: Invests $18 Million in NJ Bio and Aruka Bio for ADC Strategy Cohance Lifesciences Limited is set to strengthen its Antibody-drug Conjugate (ADC) strategy with two proposed transactions: an additional $13…